Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/27/2012US20120328714 Early detection and treatment of lung cancer
12/27/2012US20120328712 Carbon monoxide releasing rhenium compounds for medical use
12/27/2012US20120328709 Methods of dissolving blood clots and the like
12/27/2012US20120328708 Disinfectant composition and its use in dental treatment
12/27/2012US20120328707 Multi-particulate pharmaceutical formulation for colon absorption
12/27/2012US20120328706 Polymer particle delivery compositions and methods of use
12/27/2012US20120328705 Magnetic nanomedicine for tumor suppression and therapy
12/27/2012US20120328704 Powder compositions for inhalation
12/27/2012US20120328703 Swellable particles for drug delivery
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328698 Coating method
12/27/2012US20120328696 Anti-parkinsonian compound acetylsalicylic acid maltol ester
12/27/2012US20120328695 Compositions and methods for treatment of chronic fatigue
12/27/2012US20120328694 Therapeutic agent for fibroid lung
12/27/2012US20120328691 Anilinopiperazine derivatives and methods of use thereof
12/27/2012US20120328688 Biocompatible film with variable cross-sectional properties
12/27/2012US20120328687 Formulations of selective alpha-2 agonists and methods of use thereof
12/27/2012US20120328686 Pharmaceutical Composition Comprising miRNA-100 And Its Use in the Modulation Of Blood Vessel Growth and Endothelial Inflammation
12/27/2012US20120328683 Alkylaminoalkyl oligomers as broad-spectrum antimicrobial agent
12/27/2012US20120328679 Solid pharmaceutical dispersions with enhanced bioavailability
12/27/2012US20120328675 Film preparation containing medicament with unpleasant taste
12/27/2012US20120328674 Non-toxic and environmentally compatible photo-protective preparations
12/27/2012US20120328671 Composition
12/27/2012US20120328670 Targeted Delivery of Retinoid Compounds to the Sebaceous Glands
12/27/2012US20120328668 Modified sirna molecules and uses thereof
12/27/2012US20120328664 Liquid formulations
12/27/2012US20120328661 Coumarin compounds as receptor modulators with therapeutic utility
12/27/2012US20120328656 Compositions and methods for vaccinating against hsv-2
12/27/2012US20120328653 Modified immunization vectors
12/27/2012US20120328638 Mybl2 peptides and vaccines containing the same
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328633 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
12/27/2012US20120328631 Ep1 inhibition
12/27/2012US20120328630 Methods for treating and/or limiting development of diabetes
12/27/2012US20120328629 Therapeutic Applications Targeting SARM1
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328627 Chemokine receptor antagonists and use thereof
12/27/2012US20120328619 Trispecific Therapeutics Against Acute Myeloid Leukaemia
12/27/2012US20120328617 Method for inhibiting angiogenesis
12/27/2012US20120328611 Substituted triazolopyridines
12/27/2012US20120328610 Triazolopyridines
12/27/2012US20120328609 Modulation of Axon Degeneration
12/27/2012US20120328602 Compositions and methods for treating conditions associated with ceramide biosynthesis
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328593 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
12/27/2012US20120328588 Compound preparation and its uses for prevention and treatment of hearing impairment
12/27/2012US20120328585 Nutritional Composition Having Prebiotic
12/27/2012US20120328584 Biological Pacemaker
12/27/2012US20120328580 Compounds that enhance atoh1 expression
12/27/2012US20120328573 Composition for Maintaining Healthy Kidney Function
12/27/2012US20120328570 Hepatitis C Virus Inhibitors
12/27/2012US20120328569 Inhibitors of hepatitis c virus ns5b polymerase
12/27/2012US20120328565 Antiviral compounds
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328553 Method and antibacterial/antimicrobial compositions in dental compositions
12/27/2012US20120328549 Oil compositions
12/27/2012US20120328544 Dermatological Treatment Methods And Formulations
12/27/2012US20120328543 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail
12/27/2012US20120328541 Anti-radical agents
12/27/2012US20120328540 Cysteinyl compounds, compositions and methods of use
12/27/2012US20120328537 Topical wound management formulation
12/27/2012US20120328533 Hypnotic compositions and methods of use thereof
12/27/2012US20120328531 Stable liquid desoximethasone compositions with reduced oxidized impurity
12/27/2012US20120328530 Toluidine blue derivatives as photosensitising compounds
12/27/2012US20120328526 Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
12/27/2012US20120328523 Polyhydroxyalkanoates for in vivo applications
12/27/2012US20120328520 Conjugate with target-finding ligand and use thereof
12/27/2012US20120328519 Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases
12/27/2012US20120328518 Prostate specific membrane antigen inhibitors
12/27/2012US20120325209 Method for treating early severe diffuse acute respiratory distress syndrome
12/27/2012DE102011051308A1 Herstellungsverfahren und Arzneiform Manufacturing processes and pharmaceutical form
12/27/2012CA2877586A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012CA2877474A1 Compounds and therapeutic uses thereof
12/27/2012CA2876169A1 Methods of preventing or treating disease states related to certain metabolic abnormalities
12/27/2012CA2844367A1 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
12/27/2012CA2842742A1 Phenocopy model of disease
12/27/2012CA2842136A1 Multivalent [beta] - 1 - 2 - linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
12/27/2012CA2841203A1 Apoptosis-inducing agent
12/27/2012CA2840875A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
12/27/2012CA2840380A1 Selective inhibitors of histone deacetylase isoform 6 and methods thereof
12/27/2012CA2840376A1 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
12/27/2012CA2840373A1 Compounds and methods of prophylaxis and treatment regarding nicotinic receptor antagonists
12/27/2012CA2840363A1 Compositions and methods for treatment of chronic fatigue
12/27/2012CA2840354A1 Novel formulations and methods for treating dermatological disorders or diseases
12/27/2012CA2840309A1 Process for the preparation of dexlansoprazole
12/27/2012CA2840272A1 Prevention and treatment of inflammatory conditions
12/27/2012CA2840131A1 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
12/27/2012CA2840112A1 7-azaindole derivatives which are suitable for the treatment of cancer diseases
12/27/2012CA2840017A1 Compounds for the treatment of cancers associated with human papillomavirus
12/27/2012CA2840003A1 Compounds for treating peripheral neuropathies and other neurodegenerative disorders
12/27/2012CA2839958A1 Heterocyclyl aminoimidazopyridazines
12/27/2012CA2839956A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
12/27/2012CA2839946A1 Tobacco chewing gum formulation
12/27/2012CA2839896A1 Assays and methods for determining activity of a therapeutic agent in a subject
12/27/2012CA2839827A1 New family of analogues and nadp+ or nadph, their preparation and their application in therapeutics
12/27/2012CA2839825A1 Crystal of fused heterocyclic compound
12/27/2012CA2839819A1 Hydrophobic polymer compound having anticoagulant effect
12/27/2012CA2839807A1 Combination therapy
12/27/2012CA2839777A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012CA2839767A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 7860